… risk of venous thrombosis in oral contraceptive users, particularly in carriers of factor V Leiden
, we … , on the protein C pathway in the absence or presence of the factor V Leiden mutation. …

… oral contraceptives. We defined the following conditions for the contraindicated use of
contraceptives: … use in users of oral contraceptives and the factors associated with contraindication …

… (16) we found decreased levels of factor V during desogestrel-containing oral contraceptives.
The clinical relevance of this observation is not known. Several studies showed that …

… Under a multiplicative model, total risk of joint presence of factor VIII and oral contraceptive
use would be 4.0 5.3 = 21.2. The observed data are very close to the additive expectation, as …

… Factor V Leiden was not a risk factor for recurrence in two large … with factor V Leiden (compared
with noncarriers of factor V Leiden). In multivariate analysis, the presence of either factor …

… the presence of high Factor VIII levels and oral contraceptive … High levels of factor VIII are
a common risk factor for venous … the presence of high factor VIII levels and oral contraceptive (…

… use of low-dose combined oral contraceptives affects the risk of … included in the oral
contraceptive (levonorgestrel as … the presence of the G1691A mutation in the factor V gene (factor …

… ) or the presence (LYSplus) of a blocking anti-factor XI antibody … were found in women without
factor V Leiden. Women with … In conclusion, the effect of oral contraceptives on fibrinolytic …

… the presence of interaction between thrombophilia and venous thromboembolism among
women taking oral contraceptives… observed with factor V Leiden and use of oral contraceptives (…

… factor for venous thrombosis, independent of the presence or … -containing contraceptive
pill, 22 women an oral contraceptive … oral contraceptive containing norethindrone (Table 1). …